PRA Health Sciences, Inc. (the “Company”) (PRAH) today announced the pricing of the previously announced secondary offering of shares of its common stock.  KKR PRA Investors L.P. (the “Selling Stockholder”), has agreed to sell an aggregate of 6,666,684 shares of the Company’s common stock in an underwritten public offering at a price of $97.50 per share. In addition, the Company announced that, subject to the completion of the offering, it intends to repurchase from the underwriter, out of 6,666,684 shares of common stock, a number of shares having an aggregate purchase price of $300 million at a price per share equal to the price at which the underwriter will purchase the shares from the Selling Stockholder. The Company intends to fund the repurchase of common stock from the Selling Stockholder with the proceeds of a $300 million incremental term loan under its existing credit facilities.

source https://finance.yahoo.com/news/pra-health-sciences-inc-announces-100000293.html?.tsrc=rss